Patel et al. demonstrated that CTLA-4-positive, PD-1-negative T cells are highly enriched in cHL tissues, often outnumbering PD-1-expressing cells and preferentially localizing near HRS cells, which express CD86, the ligand for CTLA-4 [8]. This evidence concerns the gene CD86 and classic Hodgkin lymphoma.